| Annie Rose Palmer, NP | |
|
1005 Atlantic Ave, Alameda, CA 94501-1148 | |
| (415) 474-7310 | |
| Not Available |
| Full Name | Annie Rose Palmer |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Psychiatric/mental Health |
| Location | 1005 Atlantic Ave, Alameda, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083169064 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 21227 (California) | Secondary |
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | 21227 (California) | Primary |
| Entity Name | Felton Institute |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144551581 PECOS PAC ID: 7719025550 Enrollment ID: O20091116000112 |
News Archive
Allogeneic haematopoietic stem cell transplantation can be considered for chronic- and accelerated-phase chronic myeloid leukaemia patients with prior exposure to second-generation tyrosine kinase inhibitors, say Polish researchers.
Targacept, Inc. today announced top-line results from a Phase 2 trial of TC-5619 as a treatment for inattentive-predominant attention deficit/hyperactivity disorder (ADHDi). In the trial, TC-5619 did not meet the primary outcome measure, change from baseline on the inattention subscale of the Conners' Adult ADHD Rating Scale-Investigator-Rated (CAARS-INV), after four weeks of treatment versus placebo.
A study led by researchers at The University of Texas MD Anderson Cancer Center found that axi-cel, an autologous anti-CD19 chimeric antigen receptor (CAR) T cell therapy, is a safe and effective first-line therapy for patients with high-risk large B-cell lymphoma (LBCL), a group with an urgent need for new and effective treatments.
It is widely known that genomics has already begun to influence medicine and that bioinformatics holds the key for developing new medical approaches, but how does medical genomics really work?
ImaCor Inc., the developer of the world's only hemodynamic transesophageal echocardiography management device, announced today that transplant and mechanical circulatory support physicians from around the world gathered in Montreal at an hTEE symposium to hear from heart failure experts about the value of hTEE management.
› Verified 6 days ago
| Entity Name | By The Bay Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255381547 PECOS PAC ID: 4587638325 Enrollment ID: O20100615000148 |
News Archive
Allogeneic haematopoietic stem cell transplantation can be considered for chronic- and accelerated-phase chronic myeloid leukaemia patients with prior exposure to second-generation tyrosine kinase inhibitors, say Polish researchers.
Targacept, Inc. today announced top-line results from a Phase 2 trial of TC-5619 as a treatment for inattentive-predominant attention deficit/hyperactivity disorder (ADHDi). In the trial, TC-5619 did not meet the primary outcome measure, change from baseline on the inattention subscale of the Conners' Adult ADHD Rating Scale-Investigator-Rated (CAARS-INV), after four weeks of treatment versus placebo.
A study led by researchers at The University of Texas MD Anderson Cancer Center found that axi-cel, an autologous anti-CD19 chimeric antigen receptor (CAR) T cell therapy, is a safe and effective first-line therapy for patients with high-risk large B-cell lymphoma (LBCL), a group with an urgent need for new and effective treatments.
It is widely known that genomics has already begun to influence medicine and that bioinformatics holds the key for developing new medical approaches, but how does medical genomics really work?
ImaCor Inc., the developer of the world's only hemodynamic transesophageal echocardiography management device, announced today that transplant and mechanical circulatory support physicians from around the world gathered in Montreal at an hTEE symposium to hear from heart failure experts about the value of hTEE management.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Annie Rose Palmer, NP 1005 Atlantic Ave, Alameda, CA 94501-1148 Ph: (415) 474-7310 | Annie Rose Palmer, NP 1005 Atlantic Ave, Alameda, CA 94501-1148 Ph: (415) 474-7310 |
News Archive
Allogeneic haematopoietic stem cell transplantation can be considered for chronic- and accelerated-phase chronic myeloid leukaemia patients with prior exposure to second-generation tyrosine kinase inhibitors, say Polish researchers.
Targacept, Inc. today announced top-line results from a Phase 2 trial of TC-5619 as a treatment for inattentive-predominant attention deficit/hyperactivity disorder (ADHDi). In the trial, TC-5619 did not meet the primary outcome measure, change from baseline on the inattention subscale of the Conners' Adult ADHD Rating Scale-Investigator-Rated (CAARS-INV), after four weeks of treatment versus placebo.
A study led by researchers at The University of Texas MD Anderson Cancer Center found that axi-cel, an autologous anti-CD19 chimeric antigen receptor (CAR) T cell therapy, is a safe and effective first-line therapy for patients with high-risk large B-cell lymphoma (LBCL), a group with an urgent need for new and effective treatments.
It is widely known that genomics has already begun to influence medicine and that bioinformatics holds the key for developing new medical approaches, but how does medical genomics really work?
ImaCor Inc., the developer of the world's only hemodynamic transesophageal echocardiography management device, announced today that transplant and mechanical circulatory support physicians from around the world gathered in Montreal at an hTEE symposium to hear from heart failure experts about the value of hTEE management.
› Verified 6 days ago
Mrs. Mary Ann Sarreal Gelera, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 516 Willow St, Alameda, CA 94501 Phone: 510-714-8097 Fax: 510-667-3933 | |
Miss Catherine Ann Guthrie, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2433 Central Ave Ste 100, Alameda, CA 94501 Phone: 510-521-2300 Fax: 510-521-7947 | |
Susan Nicole Alford, CPNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1332 Park St Ste 200, Alameda, CA 94501 Phone: 510-523-3123 | |
Ms. Rikki Jacqueline Rodriguez, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2070 Clinton Ave, Suite #400, Alameda, CA 94501 Phone: 510-864-1800 | |
Ms. Kara Olsen Theiding, WHNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 112 Avington Rd, Alameda, CA 94502 Phone: 510-846-0200 | |
Allison Dong, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2690 5th St Ste B, Alameda, CA 94501 Phone: 510-439-9447 |